Sun Pharma posts Rs 1276 cr loss in Q1 on patent settlement

Drug firm Sun Pharmaceutical Industries reported a net loss of Rs 1,276.10 crore for the first quarter ended June 30, 2013, mainly on account of payment for patent litigation settlement.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved